Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Pulmonary Arterial Hypertension (PAH) - Pipeline Assessment and Market Forecasts to 2016 Now Available at ReportsandReports
GlobalData’s report, “Pulmonary Arterial Hypertension (PAH) – Pipeline Assessment and Market Forecasts to 2016” provides an essential source of information and analysis on the global PAH market. The report identifies the key trends shaping and driving the global PAH market. - June 26, 2010 - ReportsandReports
Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016 Now Available at ReportsandReports
GlobalData, the industry analysis specialist, has released a new report, “Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016.” The report is an essential source of information and analysis on the global dyslipidemia market. The report identifies the key trends shaping and driving the global dyslipidemia market. - June 26, 2010 - ReportsandReports
Nutricap Labs Wins Stevie® Award in 8th Annual American Business Awards
New York-based vitamin and supplement manufacturing company named 2010’s Best Overall Company of the Year by American Business Awards during ceremony at Marriott Marquis Hotel in New York City. - June 23, 2010 - Nutricap Labs
MedPro Rx, Inc. Sponsored Virginia Hemophilia Foundation Annual Meeting
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses who need clotting factor, IVIg and other medication, has announced that the pharmacy sponsored the Virginia Hemophilia Foundation annual meeting, held May... - June 18, 2010 - MedPro Rx, Inc.
Top Pharma Company Signs Contract with Skila for iKOL Solution
A global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health has selected Skila’s iKOL™ Expert Database solution. This company has identified iKOL™, the dynamic thought leader intelligence and insight tool, as the... - June 18, 2010 - SkilaMederi
Two Top Pharma Clients Extend and Expand Contracts with Skila
Skila, the life science industry’s leading provider of knowledge agility and stakeholder collaboration management solutions, announces the extension and expansion of solution contracts with two top Pharma companies. The extension of the term and scope of Skila’s iAdvocate™ opinion... - June 18, 2010 - SkilaMederi
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO
AdvantaPure(R) Expands Its Silicone Molding Operations — Again — to Increase Product Output
The high-purity products group of NewAge Industries, AdvantaPure, expanded its operations in 2008 and recently did so again to meet the demand for its single use systems and molded components used in pharmaceutical and biopharmaceutical production. AdvantaPure converted existing space into cleanrooms for the manufacture of silicone manifolds and container closures. Former office space at the company’s headquarters outside Philadelphia, PA, is also undergoing conversion. - June 11, 2010 - NewAge Industries, Inc.
Health Decisions CEO Explores Adaptive Monitoring Techniques for Late-Stage Clinical Studies in June 14 DIA Session
Dr. Michael Rosenberg will describe how fast access to metrics, flexible processes, and automated technology enable study monitors to increase efficiency - June 10, 2010 - Health Decisions
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition Report Now Available on ReportsandReports
Viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 22 suppliers, representative of those active in this market. - June 10, 2010 - marketsandmarkets
ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, Dr. Hebert will be charged with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA, Rat Proinsulin ELISA, Mouse C-peptide... - June 09, 2010 - ALPCO
The Name Has Changed But the Mission Remains the Same. Edwards Cabusao Group is Now Edwards Communications Group. Empowering People of Color Through Patient Education.
Edwards Communications Group, Inc., a minority owned integrated health care marketing firm is concerned about the increasing rate of diseases among minorities and is committed to changing the multicultural market on issues of health, wellness and prevention. - June 07, 2010 - Edwards Communications Group, Inc.
Lupus Research Institute Hails Results of CellCept® Trial in People with Lupus Kidney Disease
The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are very encouraged by trial results released by Vifor Pharma, Galencia Group, and Roche demonstrating that the drug CellCept® (mycophenolate mofetil) helps in maintaining remission of lupus... - June 05, 2010 - Lupus Research Institute
David Batten Appointed as President of Skila
Moish Tov, Chairman and CEO of Skila, is pleased to announce the appointment of David Batten to the newly created position of President. In this role, Batten will lead the organization's strategic planning, partnership and M&A initiatives. "I am pleased and excited to have David join our Executive leadership team and benefit from his experience and dedicated contributions towards the growth and future of our organization," says Tov. - June 03, 2010 - SkilaMederi
Elder Pharmaceuticals’ R&D Division Creates a Novel Drug Delivery System (NDDS) for a Nutraceutical Formulation
Elder to file for worldwide patents. The company is expecting a turnover of Rs 30 crore from this product by 2012 - May 31, 2010 - SPR P Ltd
BDA Advises Pfizer on Divestment of Animal Vaccine Business in China to Harbin Pharmaceutical
Pfizer Inc (NYSE: PFE), advised by Business Development Asia LLC, has sold its market-leading swine vaccine business in China to Harbin Pharmaceutical Group. - May 29, 2010 - BDA Partners Ltd
Health Decisions Encourages DIA Attendees to Demand More Than the Industry’s 10% Rate of On-Time Enrollment in Clinical Trials (Booth 929)
CRO demonstrates techniques that reverse the tide of enrollment delays in clinical research. - May 29, 2010 - Health Decisions
Interphex 2010 Proves Successful for Single Use Systems Manufacturer AdvantaPure
Attendees at Interphex 2010, held last month in New York City, showed interest in AdvantaPure’s single use systems for pharmaceutical and biopharmaceutical manufacturing. The company’s tubing, hose, and identification solutions also drew interest. Attendees asked many questions about how AdvantaPure’s new products could increase speed and efficiency in their drug and vaccine production processes. - May 27, 2010 - NewAge Industries, Inc.
New U.S. Patent Grant to Foamix for Its Hygroscopic and Waterless Breakable Foam Technology
The patent describes unique pharmaceutical foams and their use to deliver a wide range of active agents to treat skin and body cavity conditions. - May 21, 2010 - Foamix Ltd
IonSense Issued Three Patents Related to Direct Analysis in Real Time Mass Spectrometry
Supports Current Products and Applications in Food Safety, Pharmaceutical Development, and Forensics - May 20, 2010 - IonSense, Inc.
Jean Brown Research Announces Participation in a Phase II/III Clinical Trial of Investigational Vaccine Used to Prevent Infection in Cardiothoracic Surgery Patients
Jean Brown Research Announces Its Participation in a Phase II/III Clinical Trial of an Investigational Vaccine Used to Prevent Staphylococcus Aureus Infection in Patients Undergoing Cardiothoracic Surgery. - May 19, 2010 - Jean Brown Research
Clinical Trials in Russia. 1st Quarter 2010.
The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 134 new clinical trials of all types including local and bioequivalence studies during the first quarter of 2010 demonstrating an 18% increase over the corresponding period of last year. - May 19, 2010 - Synergy Research Group
VIRUN® to Premiere OmegaH2O® Through WEDAR at CPhI and HI/NI in Shanghai, China
Virun to premiere water soluble and shelf stable OmegaH2O® in China through WEDAR Biotechnology Co. Ltd. OmegaH2O® is patents pending. - May 18, 2010 - VIRUN
Suboxone Clinic to Treat Addiction to Pain Killers Like Vicodin, Oxycontin and Heroin, in El Paso, Texas
Many people are addicted to pain killers and are unable to discontinue them because of fear of the severe withdrawal symptoms. Addiction to pain killers destroys lives, marriages, and can lead to serious legal problems. Help is now available in El Paso, Texas, without hospitalization. - May 16, 2010 - Atlantis Health Services
CIS Launches Newest CalcPartner Release to Address Recent Healthcare Reform Legislation
CIS has announced the latest release of its government pricing calculation system, CalcPartner(TM) 2.0. This release includes the flexibility to quickly address regulatory changes to calculations, such as the new Unit Rebate Amount (URA) and the new Average Manufacturer Price (AMP) reporting provisions mandated in new healthcare reform legislation. - May 13, 2010 - Compliance Implementation Services
Nutricap Labs Executive Vice President Named Finalist for 2010 Ernst & Young Entrepreneur of the Year Award
Leader of New York-based vitamin and supplement manufacturing company honored by one of the world’s leading professional services organizations for his vision, courage, and achievements over the past year. Jason Provenzano, Executive Vice President of Nutricap Labs, a New York-based vitamin... - May 10, 2010 - Nutricap Labs
CIS Presents at Medicaid Event, Launches New Industry Blog
CIS announced today that three of its Government Programs experts will be speaking at CBI’s 12th Annual Medicaid Rebates Conference being held May 12 – 14 at Lake Buena Vista, Florida, USA. In addition to its speaking engagement at and sponsorship of the CBI Medicaid event, CIS will launch its improved Pharma Compliance Blog from its booth on the exhibit floor. - May 09, 2010 - Compliance Implementation Services
XTractor Premium Crosses 1 Million Manually Annotated Relationships
XTractor Premium, a biomedical search engine has surpassed 1 million relationships, “Expert annotated facts from PubMed.” - May 09, 2010 - Molecular Connections Pvt. Ltd.
CIS Helping Pharma Companies Build a Compliance Community One Blog at a Time
Compliance Implementation Services has launched its new blog platform -- pharmacomplianceblog.com -- that will provide users with easier access to the latest regulatory compliance articles, legislative summaries, Healthcare Reform updates, and government agency news. - May 08, 2010 - Compliance Implementation Services
CIS Adds TRICARE Specialist to Assist Clients with New Legislation
Compliance Implementation Services (CIS) announced today that Lisa C. McNair has joined the firm as Senior Manager of TRICARE Contracting. - May 05, 2010 - Compliance Implementation Services
New SensoLyte® SIRT1 Assay Kit Offers Industry’s Longest Wavelength
AnaSpec has introduced SIRT1 assay kits in the green range (Ex/Em=490/520 nm). - May 02, 2010 - AnaSpec, EGT Group
Foamix Receives a New U.S. Patent for Its Emollient and Aqueous Foam Technology
The Patent Covers Foams with Urea, Lactic Acid, Salicylic Acid and Penetration Enhancers - May 01, 2010 - Foamix Ltd
Health Decisions CEO to Explore the Role of Operations in Adaptive Research at Adaptive Designs for Clinical Drug Development, April 29
Michael Rosenberg, founder of adaptive-focused CRO, will discuss how flexible clinical operations support the new FDA Draft Guidance on adaptive design - April 25, 2010 - Health Decisions
Themis Analytics Wins Queen’s Award for Enterprise in International Trade 2010
Themis Analytics, a leading provider of business intelligence and marketing information services and solutions for the global pharmaceutical industry, is announced today as a winner of the coveted Queen’s Award for Enterprise in International Trade. - April 23, 2010 - Themis Analytics
Bio-Med QC, LLC Announces New Test Procedure to Yield Improved USP Results
Bio-Med QC, LLC announced a new test procedure at the Indian Pharmacists Alliance & Community Pharmacies of Indiana Joint Annual Convention in Indianapolis to improve proficiency test results by an additional 5% when conducting quality system tests of personal aseptic technique. USP Chapter... - April 22, 2010 - Bio-Med QC
Saladax Biomedical Expands Executive Team with New VP of Clinical Development and Regulatory Affairs
Gary Feiss joins Saladax Biomedical to lead clinical development for the MYCARE™ portfolio of personalized medicine assays, as well as supporting companion diagnostic development programs undertaken in collaboration with pharmaceutical partners. - April 19, 2010 - Saladax Biomedical, Inc.
Michigan Compounding Pharmacy Launches New Drug Take-Back Program for Consumer Drug Disposal
Health Dimensions Compounding Pharmacy launches new plan to take back old and unwanted medications. - April 16, 2010 - Health Dimensions Compounding Pharmacy
Health Decisions Expands the Agile Clinical Network with the Addition of African CRO ClinResearch
International research network’s continued growth strengthens its aim to raise standards of efficiency and quality for global clinical trials. - April 15, 2010 - Health Decisions
Compliance Consultant Elected to PDMA Alliance Board of Directors
Compliance Implementation Services (CIS) announced today that Judy Fox, CIS Director for U.S. Global Compliance, has been elected to the PDMA Alliance Inc. Board of Directors. - April 14, 2010 - Compliance Implementation Services
SigmaPhone Expanded iPharmacy, One of the Best Selling Medical Apps on Apple App Store, to Include 7,000 Drugs
SigmaPhone LLC has expanded iPharmacy to include the most comprehensive drug library (7000), as well as new medical assistant features for consumer, such as adding personal reminder to favorite drugs. - April 08, 2010 - Sigmaphone.com
CIS Takes Government Calculations Service to Next Level with New Director
Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that Matt Gorman has joined the management team as Director of Government Pricing Programs. - April 07, 2010 - Compliance Implementation Services
XTractor Premium Expands Its Knowledgebase of Accurate Biomedical Facts for Researchers as It Surpasses 850,000 Mark
XTractor Premium, has surpassed 850,000 relationships, is a new generation of intelligent search engines-A semantic web platform. - April 04, 2010 - Molecular Connections Pvt. Ltd.
RegLink Associates Welcomes FDA's First Draft Guidance on Risk Evaluation & Mitigation Submission (REMS)
RegLink Associates' Principal, Ansis Helmanis, welcomes FDA's first draft guidance to help companies better understand what is expected in risk evaluation and mitigation strategy submissions. Obligations to fund and support costly studies can extend beyond the date of exclusivity, giving follow-on competitors an advantage. - April 01, 2010 - RegLink Associates
New Hire to Facilitate Client Integrations and Address Evolving Industry Needs
Daniel Farina has joined Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, as CalcPartner and ClaimsPartner Operations Manager and Integration Lead. - March 31, 2010 - Compliance Implementation Services
Affinity Life Science and JSW Life Sciences Ink Strategic Partnership
Affinity Life Sciences, Inc. and JSW Life Sciences have agreed to a Strategic Partnership designed to expand their capabilities and enhance their service offerings. - March 18, 2010 - Affinity Life Sciences
ICTS Article Published in Future Pharmaceuticals
Tom Sturgis, president of ICTS (Integrated Clinical Trial Services, LLC) (www.icts.us), has announced that the company’s article, “Improve Site Performance,” was published in the March 2010 issue of Future Pharmaceuticals. An accompanying podcast interview was featured on the... - March 18, 2010 - Integrated Clinical Trial Services
New ADHD Memoir Debunks Long Standing and Entrenched Educational Policies While Exploring Pertinent Issues Such as Adderall Abuse, Learning Style, and Stigmatization
"mADD man," is the beautifully written and magnificently dark memoir by author, Brian J. Robinson. It digs deeply and often brutally into ADHD, Adderall abuse, Hollywood, philosophy, rebellion, Judaism, Tulane, New Orleans, and the unique perspective of someone With ADHD. This is not a clinical perspective. - March 16, 2010 - mADD man
Logicden Launches Drug Medical Information (DMI) Software, Along with Search Request Manager (SRM) and Drug Literature Knowledgebase (DLK) for Pharmaceuticals
Logicden proudly announces the launch of a software-suite for managing published literature in the life sciences at the 21st DIA Annual Workshop at the Medical Communications conference, sponsored by the Drug Information Association. This premier event which attracts writers and information... - March 13, 2010 - Soft Pro Internationa Inc., dba Logicden
New Hire Brings Pharmaceutical Manufacturing Compliance Expertise
Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, is pleased to announce that Venessa Piper-Givler has joined the management team as Director of Manufacturing Compliance. Venessa Piper-Givler has 20 years of diverse pharmaceutical industry experience, including... - March 12, 2010 - Compliance Implementation Services
An Attorney for You helping Patients Affected by New Potential Avandia Recall Lawsuits
Senate study says the drug maker, GlaxoSmithKline knew that heart attacks were likely tied to Avandia. - March 09, 2010 - An Attorney for You